NEW YORK (GenomeWeb) – The GenomeWeb Index outperformed the broader stock market for a third month in a row in June, gaining nearly 5 percent.

The index outperformed the Dow Jones Industrial Average, which lost half a percent; the Nasdaq, which gained nearly 1 percent; and the Nasdaq Biotechnology Index, which was up 1 percent. Stock performance in the June GenomeWeb Index was largely positive, as 17 of the 26 stocks saw gains and nine saw losses.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.